Company profile
AI Maverick Intel, Inc.
OTC: AIMV · Healthcare · Medical - Specialties
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 45
v0.1 · 5/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ workforce scale, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
—
Employees
5
as of 2026-08-23
Market cap
$8.3M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is AI Maverick Intel, Inc.’s financial profile?
AI Maverick Intel, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
CalciMedica, Inc.——CNS Pharmaceuticals, Inc.——AEON Biopharma, Inc.——Aprea Therapeutics, Inc.——Univec, Inc.——Apimeds Pharmaceuticals US, Inc——Neighbors
Los Angeles →Key facts
CEOWayne Douglas Cockburn
SectorHealthcare
IndustryMedical - Specialties
HeadquartersBeverly Hills, CA
ExchangeOTC: AIMV
Employees5
IPO date2007-06-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.